• Zoledronic Acid Workflows for Cancer and Bone Models

  2026-08-17

  Build more reliable Zoledronic Acid studies by separating formulation, exposure, apoptosis, and bone-remodeling endpoints. This workflow connects cancer-cell assays with osteolytic disease models while using orthogonal validation strategies inspired by a recent immunometabolic study.

• Pam3CSK4 TFA: Practical TLR1/2 Assay Workflows

  2026-08-16

  Pam3CSK4 TFA provides a defined way to model TLR1/2-driven innate immune activation, from cytokine screening to maternal-neonatal inflammation studies. This guide translates recent IL-17A findings into reproducible assay design, concentration screening, controls, and troubleshooting decisions.

• EdU Imaging Kits (488) for HAUS1 and HCC Research

  2026-08-15

  EdU Imaging Kits (488) provide a precise way to connect S-phase DNA synthesis measurement with HAUS1-driven hepatocellular carcinoma biology. This article presents a hypothesis-focused assay framework for separating proliferation, cell-cycle effects, and biomarker association.

• Ferritin Hybrid Particles for Dual-Virus Vaccination

  2026-08-14

  The reference study develops an Escherichia coli-produced ferritin hybrid particle that co-displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes. In mice, the construct produced stronger antigen-specific responses and functional antibody activity than antigen-only or homologous ferritin-fusion comparators, supporting ferritin co-assembly as a combination-vaccine strategy.

• CCK8 Workflow for Viability and Cytotoxicity

  2026-08-14

  Build a reproducible cck8 workflow for cell viability measurement, compound screening, and proliferation studies. Learn how to pair Cell Counting Kit-8 readouts with inflammatory bioassays, control metabolic confounders, and troubleshoot weak or misleading signals.

• RNA Clean and Concentrator Kit for RNA Cleanup

  2026-08-13

  The RNA Clean and Concentrator Kit converts messy transcription and RNA-binding reactions into clean, concentrated material for structural, biochemical, and virology assays. Its membrane-based workflow is especially useful when unincorporated NTPs, proteins, salts, and short oligonucleotides could distort downstream measurements.

• Cinoxacin In Vitro Activity Against Gram-Negative Bacilli

  2026-08-13

  Lumish and Norden’s 1975 study established a quantitative in vitro profile for Cinoxacin across 419 clinical isolates, showing strongest activity against Enterobacterales and limited activity against Pseudomonas aeruginosa and Gram-positive organisms. Its integrated use of agar dilution, disk diffusion, bactericidal testing, and serial passage provided an early framework for susceptibility testing and antibiotic resistance studies involving this quinolone antibiotic.

• 2'3'-cGAMP: STING Assay Workflows

  2026-08-12

  Build cleaner cGAS-STING experiments with 2'3'-cGAMP (sodium salt) as a defined downstream STING control, rather than relying only on variable DNA-sensing stimuli. The workflow connects pathway activation, type I interferon induction, PD-L1 biology, and TOP1-linked cancer research while addressing solubility, uptake, timing, and assay-specific troubleshooting.

• TSPAN18–STIM1 Axis in Prostate Cancer Bone Metastasis

  2026-08-12

  Zhou et al. identified TSPAN18 as a binding partner that protects STIM1 from TRIM32-mediated ubiquitination and degradation, thereby amplifying store-operated calcium entry in prostate cancer cells. The study connects this post-translational mechanism to migration, invasion, bone metastasis, and adverse clinical features, while positioning TSPAN18 as a candidate target for mechanistic prostate cancer research.

• Calpain Inhibitor I, ALLN: Practical Workflow Guide

  2026-08-11

  Calpain Inhibitor I, ALLN (SKU A2602) is a research inhibitor for calpain I, calpain II, and selected cathepsins, supporting controlled protease perturbation in apoptosis, inflammation, and ischemia-reperfusion workflows. This guide covers preparation, controls, assay setup, and interpretation while emphasizing that the compound is not intended for diagnostic, clinical, or therapeutic use.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-08-11

  The reference study shows that liver metastasis-associated macrophages are maintained through more than simple replacement of Kupffer cells by recruited monocytes. By combining lineage tracing, proliferation recording, flow cytometry, and CITE-seq, the authors identify compensatory local proliferation and infiltration of reprogrammed Kupffer cells as parallel sources of immunosuppressive macrophages.

• MK-5108: Precision Aurora A Assay Strategy

  2026-08-10

  MK-5108 (VX-689) is a highly selective Aurora A inhibitor for dissecting mitotic control and tumor cell proliferation. This article translates retinoblastoma evidence into practical assay-design decisions, emphasizing target validation, selectivity, and xenograft interpretation.

• ddhCTP Assays: From Chain Termination to Insight

  2026-08-09

  Explore how ddhCTP, or 3ʹ-deoxy-3′,4′-didehydro-CTP, can distinguish direct viral polymerase inhibition from broader viperin-mediated antiviral mechanisms. This evidence-led guide translates recent coronavirus findings into practical assay decisions for flavivirus and RNA virus research.

• MnTBAP Chloride: Designing Mitochondrial Redox Assays

  2026-08-08

  MnTBAP Chloride is a cell-permeable SOD mimetic for investigating mitochondrial superoxide, inflammation, and redox signaling. This guide translates chronic-stress findings into a practical assay framework for separating antioxidant rescue from broader behavioral and inflammatory effects.

• Viperin Targets nsp8 to Block Coronavirus Replication

  2026-08-07

  The reference study identifies a ddhCTP-independent antiviral mechanism in which viperin binds coronavirus nsp8 and disrupts replication-transcription complex assembly and RNA-dependent RNA polymerase activity. Using porcine deltacoronavirus as a model, the authors map the interaction to viperin residues 43–184 and nsp8 K82, providing a mechanistic framework for evaluating conserved anti-coronavirus targets.

15242 records 1/1017 page Next 12345 下5页 Last page